The earliest signal of
infection is already there.

We make it visible.

A continuous clinical intelligence platform for high-risk patients. 
AION combines continuous temperature monitoring with a clinical intelligence platform to give patients, caregivers, and care teams visibility into temperature patterns and meaningful changes between visits.

Powered by TempShield™, our FDA-cleared continuous temperature wearable designed to be worn for up to 90 days.

FDA

cleared

for ages 1+

Up to

90 days

continuous monitoring

5,000+

high-risk patients monitored

120+

sites nationwide

TRUSTED ACROSS THE INDUSTRY
TRUSTED ACROSS THE INDUSTRY
AWARDS

Real-world results in oncology

2–4 days

temperature changes preceding symptoms

98%

would recommend TempShield

99%

insurance approval

74%

fewer inpatient days

120 days

average time on monitoring

EXPLORE THE EVIDENCE

See what continuous temperature intelligence can make visible.

Hear from Dr. Tallat Mahmood, Medical Director at Roswell Park at Ellis Medicine; Dr. Alfredo Torres, hematologist/oncologist at New York Cancer & Blood Specialists; and the patients and families who use TempShield.

CLINICAL PERSPECTIVE

The TempShield is to high-risk patients like the glucose monitor is to diabetics. We have seen that the TempShield is the difference between an antibiotic and a hospitalization.

Dr. Tallat Mahmood

Medical Director, Roswell Park Cancer Center at Ellis Medicine

From continuous
measurement to 90 Days of connected care.

AION brings long-duration continuous temperature monitoring, connected technology, and clinical workflow together into one integrated clinical intelligence platform — combining hardware and software to ensure visibility across care settings.

TempShield™
Continuous temperature.

FDA-cleared continuous temperature monitoring designed to be worn for up to 90 days.

Longitudinal View
See change over time.

Continuous temperature data creates a longitudinal view of each patient, revealing patterns and changes that isolated measurements can miss.

CLINICALLY MEANINGFUL 
ALERTS
Signal, not noise.

Alerts fire on a sustained change, not a single spike, at thresholds set to your protocol, so when one arrives it’s worth a call. In practice, TempShield fever alerts have preceded symptoms by 2-3 days.

Connected Patient
Designed for high-risk patients.

A check engine light for infection. Continuous monitoring flags trouble days before a spot check would. Care teams get the warning instead of the emergency.

Clinician Platform
Stay connected between checks.

Care teams can remotely view current and historical temperature data throughout the monitoring period.

YOUR EXISTING WORKFLOW
Fits the workflow you already have.

Alerts arrive where care teams already work (EMR, SMS or email), not in another portal. Thresholds are set to your protocol, and monitoring is billed under existing RPM codes.

Built for the future
of cancer care.

Cancer care increasingly happens beyond the walls of the clinic. Patients can remain vulnerable to infection and serious complications throughout weeks and months of treatment. TempShield helps you keep patients on treatment, not in the hospital.

Built for the future
of skilled nursing.

Infection is one of the top three drivers of hospital readmissions from skilled nursing facilities, costing the industry more than $3 billion a year. Residents can be vulnerable to complications a spot check catches too late. TempShield helps you keep residents in the building, not the hospital.

A new way to think
about temperature.

Hear oncologists Dr. Doug Flora, Dr. Sanjay Juneja, and Dr. David Penberthy  discuss why continuous temperature monitoring matters for cancer patients and how greater visibility between visits can change the way we think about monitoring throughout treatment.